More News! Will GSK Bring to Market the First Malaria Treatment in 60 Years?

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week.

  • Sphere Fluidics, based in Cambridge, has received a  €1.6M grant from Eurostars to support the development of its DNA docking tech for genome editing.
  • Orchard Therapeutics extending is its collaboration with Manchester University to include Sanfilippo B Syndrome.

  • GSK has submitted a new drug application to the FDA for its malaria treatment to prevent relapse, which could be the first new treatment in 60 years.
  • Sotio started one of the notable biotechs in the Czech Republic, has a Phase II trial in ovarian cancer.
  • Merck missed its endpoint in a Phase III trial for a third-line gastric cancer treatment.

images via Sainam51, hkhtt hj, kunanon / shutterstock.com

SaveSave

Support good journalism, subscribe to Labiotech Insider

Labiotech Insider

If you liked this post and want to read more good journalism, support us by joining Labiotech Insider. Our Insider membership gives you access to exclusive content and other advantages.

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.